A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

@inproceedings{Kubota2015ARP,
  title={A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial},
  author={Kaoru Kubota and Hiroshi Sakai and N Katakami and Makoto Nishio and Akira Inoue and Hiroaki Okamoto and Hiroshi Isobe and Hideo Kunitoh and Yuichi Takiguchi and Kenji Kobayashi and Yoichi Nakamura and Hironobu Ohmatsu and Shunichi Sugawara and Koichi Minato and Masaaki Fukuda and Akira Yokoyama and Masahiro Takeuchi and Hiroshi Michimae and Akihiko Gemma and Shinzoh Kudoh},
  booktitle={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2015}
}
BACKGROUND Platinum-based two-drug combination chemotherapy has been standard of care for patients with advanced nonsmall-cell lung cancer (NSCLC). The primary aim was to compare overall survival (OS) of patients with advanced NSCLC between the two chemotherapy regimens. Secondary end points included progression-free survival (PFS), response, safety, and quality of life (QoL). PATIENTS AND METHODS Patients with previously untreated stage IIIB or IV NSCLC, an Eastern Cooperative Oncology Group… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS
14 Citations
23 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer

  • CG Azzoli, S Baker, Jr., S Temin
  • J Clin Oncol
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…